STEGLATRO

This brand name is authorized in United States. It is also authorized in Australia, Austria, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug STEGLATRO contains one active pharmaceutical ingredient (API):

1	Ertugliflozin L-pyroglutamic acid UNII MLU731K321 - ERTUGLIFLOZIN PIDOLATE
	Ertugliflozin helps to lower blood glucose by making the patient pass out glucose in the urine. It does this by blocking a protein in the kidneys (called SGLT2) that normally takes glucose back into the blood from the kidneys.
	Read more about Ertugliflozin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STEGLATRO Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BK04		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11570Y, 11571B, 11577H, 11585R
EE	Ravimiamet	1767472, 1767483, 1767494, 1767506, 1767517, 1767528, 1767539, 1767540, 1767551, 1767562, 1778913, 1778924
ES	Centro de información online de medicamentos de la AEMPS	1181267002, 1181267008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	199903, 485799, 491257, 531382
GB	Medicines & Healthcare Products Regulatory Agency	365149, 365152
HK	Department of Health Drug Office	66203, 66204
IE	Health Products Regulatory Authority	27573, 27698
IL	מִשְׂרַד הַבְּרִיאוּת	8311, 8456
LT	Valstybinė vaistų kontrolės tarnyba	1085283, 1085284, 1085285, 1085286, 1085287, 1085288, 1085289, 1085290, 1085291, 1085292, 1085293, 1085294, 1087677, 1087678
NL	Z-Index G-Standaard, PRK	167665, 167673
PL	Rejestru Produktów Leczniczych	100405521, 100405538
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66525001, W66525002, W66525003, W66525004, W66526001, W66526002, W66526003, W66526004
US	FDA, National Drug Code	0006-5363, 0006-5364